Men are filing low testosterone lawsuits against AndroDerm and other low testosterone therapy manufacturers. These claims come after men suffered heart attacks, strokes and cardiovascular events while using AndroDerm.
Cases Involving Low T Therapies Like Androderm More Than Doubled In June 2014 Alone
Pending low testosterone treatment cases against products like Androderm doubled in June 2014. On June 16, 2014, men filed 98 lawsuits against AndroGel, Testim, Androderm and Depo in the U.S. District Court of Illinois. On June 6, 2014, just 45 lawsuits were currently pending when a judicial panel approved a motion for multidistrict litigation. Upon the request’s approval, the panel transferred all relevant claims to the North District of Illinois. In approximately 10 days, that total number increased about 2.18 times.
FDA Issues Updated Heart Damage Warning for Androderm, Other Low T Therapies
Just two weeks after judges ordered all low-t lawsuits centralized under the MDL, the U.S. Food and Drug Administration (FDA) issued a warning. In January 2014, the agency ordered low-t therapy manufacturers to add a warning about cardiovascular risks. Then in June 2014, they ordered a general warning about venous blood clots. Venous blood clots can lead to serious cardiac events, which may prove fatal for low t therapy patients.
Court documents noted that low-T lawsuits started to be filed in January 2014 following and FDA investigation to examine the safety of prescription testosterone therapies. The investigation was sparked by two studies that found that low testosterone medications can increase the risk of heart attacks, strokes and cardiovascular-related issues.
How Victims Can Get the Justice and Compensation They Deserve
Men are finally getting the justice and compensation they deserve for low testosterone cardiovascular events. If you or someone you love suffered a heart attack or stroke while using Androderm, complete your free compensation evaluation form now. Once we receive your information, an experienced advocate will contact you to discuss your compensation options.